免疫性辐射疗法增强抗瘤免疫力通过核心外纳米复合材料介导的多重策略
Naihan Huang1, Along Qian1, Yiming Zou1
1Guangdong Provincial Key Laboratory of New Drug Screening, Guangzhou Key Laboratory of Drug Research for Emerging Virus Prevention and Treatment, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, China.
Theranostics
|August 9, 2023
概括
这项研究引入了一种新型纳米复合材料 (UMP),通过克服免疫抑制瘤微环境 (TME) 来增强放射治疗 (RT). UMP有效诱导免疫细胞死亡 (ICD),增强对各种瘤类型的抗瘤免疫力.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 癌症研究 癌症研究
背景情况:
- 瘤微环境 (TME) 通常会抑制免疫反应,限制放射治疗 (RT) 的有效性.
- 诱导免疫细胞死亡 (ICD) 对于提高RT疗效至关重要.
- 开发克服TME媒介免疫抑制的策略是癌症治疗中的迫切挑战.
研究的目的:
- 开发一种新的纳米复合材料,以改善免疫原辐射疗法.
- 研究多功能纳米复合材料在重塑瘤微环境中的协同效应.
- 通过启动强烈的免疫细胞死亡来增强抗瘤免疫力.
主要方法:
- 用聚烯酸涂层的核心外 UiO@Mn3O4 (UMP) 纳米复合材料的构造.
- 利用Mn3O4生产氧气,减少谷氨,产生活性氧物种 (ROS),并在TME中停止细胞循环.
- 使用基于Hf的UIO来增强辐射吸收,以放大RT效应.
主要成果:
- 该UMP纳米复合物通过多种综合策略有效地重塑了免疫抑制TME.
- 通过UMP介导的RT成功诱导了强烈免疫细胞死亡 (ICD).
- 这种方法促进了树突细胞的成熟,增强了CD8+ T细胞的透,并增强了针对初级,远端和转移性瘤的抗瘤免疫力.
结论:
- 开发的UMP纳米复合材料为克服TME介导免疫抑制提供了一个有希望的策略.
- 这种多方面的方法显著增强了免疫原辐射治疗的结果.
- 这些发现有助于开发先进的癌症纳米药物,以提高治疗效率.
相关概念视频
01:27Tumor Immunotherapy
557
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
557
01:30Cancer Vaccines
403
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
403
01:27Cytotoxic T Cells-mediated Immune Response
971
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
971
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K